Lifetime suicide rates in treated schizophrenia: 1875-1924 and 1994-1998 cohorts compared

British Journal of Psychiatry

Volumn 188, Issue MAR., 2006, Pages 223-228

  Healy, D ^a   Harris, M ^a   Tranter, R ^a   Gutting, P ^a   Austin, R ^a   Jones Edwards, G ^a   Roberts, A P ^a  

^a Hergest Unit   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; DATA BASE; DISEASE ASSOCIATION; HISTORICAL RESEARCH; HOSPITAL ADMISSION; HUMAN; INCIDENCE; LIFESPAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; PREVALENCE; PSYCHOSIS; RISK FACTOR; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SUICIDE; SUICIDE ATTEMPT; UNITED KINGDOM;

ADOLESCENT; ADULT; COHORT STUDIES; DEINSTITUTIONALIZATION; FEMALE; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SUICIDE; SUICIDE, ATTEMPTED; WALES;

EID: 33644757696     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.188.3.223     Document Type: Article

References (29)

1. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV) (text revision). Washington, DC: APA.
2. Anderson, O. (1987) Suicide in Victorian and Edwardian England. Oxford: Oxford University Press.
3. Beisser, A. & Blanchette, J. A. (1961) A study of suicide in a mental hospital. Diseases of the Nervous System, 22, 365-369.
4. Biswas, P. N., Wilton, L. V., Pearce, G. L., et al (2001) The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England. Journal of Psychopharmacology, 15, 265-271.
5. Bleuler, M. (1978) The Schizophrenic Disorders: Long-Term Patient and Family Studies (trans. J. M. Clemens). New Haven, CT: Yale University Press.
6. Caldwell, C. B. & Gottesman, I. (1990) Schizophrenics kill themselves too: a review of risk factors for suicide. Schizophrenia Bulletin, 16, 571-589.
7. Department of Health (2001) National Confidential Inquiry into Suicide and Homicide by People with Mental Illness. Five-Year Report. London: Department of Health.
8. Drake, R. E. & Ehrlich, J. (1985) Suicide attempts associated with akathisia. American Journal of Psychiatry, 142, 499-501.
9. Farberow, N., Ganzler, S., Cuttler, F., et al (1978) Status of Suicides in Veterans Administration Hospitals. Reports 2-4. Los Angeles, CA: Central Research Unit, V. A. Wadsworth Hospital Center.
10. Gilbert, P. L., Harris, J., McAdams, L. A., et al (1995) Neuroleptic withdrawal in schizophrenic patients. Archives of General Psychiatry, 52, 173-188.
11. Hagnell, C., Lanke, J. & Rorsman, B. (1981) Suicide rates in the Lundby study: mental illness as a risk factor for suicide. Neuropsychobiology, 7, 248-253.
12. Harris, E. C., Barraclough, B. (1997) Suicide as an outcome for mental disorders: a meta-analysis. British Journal of Psychiatry, 170, 205-228.
13. Healy, D. (2004) Shaping the intimate: influences on the experience of everyday nerves. Social Studies of Science, 34, 219-245.
14. Healy, D. & Savage, M. (1998) Reserpine exhumed. British Journal of Psychiatry, 172, 376-378.
15. Healy, D., Savage, M., Michael, P., et al (2001) Psychiatric bed utilisation: 1896 and 1996 compared. Psychological Medicine, 31, 779-790.
16. Hogan, T. P. & Awad, A. G. (1983) Pharmacotherapy and suicide risk in schizophrenia. Canadian Journal of Psychiatry, 20, 277-281.
17. Hussar, A. E. (1962) Effect of tranquillisers on medical morbidity and mortality in a mental hospital. JAMA, 179, 682-686.
18. Inskip, H. M., Harris, E. C. & Barraclough, B. (1998) Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia. British Journal of Psychiatry, 172, 35-37.
19. Mackay, F. J., Wilton, L. V., Pearce, G. L., et al (1998) The safety of risperidone: a post-marketing study of 7684 patients. Human Psychopharmacology, 13, 413-418.
20. Meltzer, H. Y., Alphs, L., Green, A. J., et al (2003) Clozapine treatment for suicidality in schizophrenia. International suicide prevention trial (InterSePT). Archives of General Psychiatry, 60, 62-91.
21. Miles, P. (1977) Conditions predisposing to suicide: a review. Journal of Nervous and Mental Disease, 164, 231-246.
22. Mortensen, P. B. & Juel, K. (1993) Mortality and causes of death in schizophrenic patients in Denmark. Acta Psychiatrica Scandinavica, 81, 372-377
23. Mosholder, A. (1993) Review and Evaluation of Clinical Data. Application NDA no. 20-272 (11 May 1993). Washington, DC: Center for Drug Evaluation and Research, Department of Health and Human Sciences.
24. Nordentoft, M., Laursen, T. M., Agerbo, E., et al (2004) Development in suicide rates for patients with schizophrenia from 1981 to 1994 in Denmark. Twelfth Winter Workshop on Schizophrenia. Schizophrenia Research, 67 (suppl. 1), 215.
25. Rennie, T. (1939) Follow-up study of 500 patients with schizophrenia admitted to hospital from 1913 to 1923. Archives of Neurology and Psychiatry, 41, 877-891.
26. Saugstad, L. & Odegard, O. (1979) Mortality in psychiatric hospitals in Norway 1950-1974. Acta Psychiatrica Scandinavica, 59, 431-447.
27. Southall, H. R., Aucott, P., Dorling, D., et al (2004) Great Britain Historical Database: Census Data, Age and Sex Statistics 1851-1971. Colchester: Essex University.
28. Tranter, R. & Healy, D. (1998) Neuroleptic discontinuation syndromes. Journal of Psychopharmacology, 12, 306-311.
29. World Health Organization (1993) The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva: WHO.